ClinicalTrials.gg
CompletedNCT02226562Updated Aug 27, 2018Results posted

Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity

A Phase 2 interventional study of Potassium nitrate and sodium fluoride and Standard fluoride dentifrice in Dentin Sensitivity, sponsored by GlaxoSmithKline. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-27.

Sponsored by GlaxoSmithKline · Phase 2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
191
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 28 studies in Dentin Sensitivity by GlaxoSmithKline — none open to participants now, none under way, none of them phase 3. Dentin Sensitivity · GlaxoSmithKline.

Enrollment
13th of 28
191 · median 164
Started
2014
with 1 other
Phase 2
6 of 28
none open now
Registered
7th of 28
by date

Among the 28 studies in Dentin Sensitivity by GlaxoSmithKline, this one is the 13th largest by enrollment, is one of 2 that started in 2014, is one of 6 in phase 2, and was the 7th registered.

Dentin Sensitivity

290 studies on the registry are indexed under Dentin Sensitivity; 48 are open to participants now.

Browse Dentin Sensitivity studies →

Open to participants now

None of the 28 studies in Dentin Sensitivity by GlaxoSmithKline is open now. The open studies under Dentin Sensitivity, anywhere →

Who these studies take

Of the 19 Dentin Sensitivity studies recruiting now, 6 (32%) set no upper age limit and 12 (63%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 28 studies in Dentin Sensitivity by GlaxoSmithKline as a file.
02

Study summary

The aim of this study is to investigate the longitudinal efficacy of a potassium nitrate mouthwash formulation when used as an adjunct to brushing with a standard fluoride dentifrice for the relief of dentinal hypersensitivity (DH) compared to brushing with a standard fluoride dentifrice alone. This will be a single centre, eight week, randomised, examiner blind, two treatment arm, parallel design, stratified (by maximum baseline Schiff Sensitivity Score of the two selected test teeth) study in participants with at least two sensitive teeth that meet all the criteria at the Screening and Baseline visit. Participants will be assessed at Baseline, and at four and eight weeks to monitor clinical efficacy and safety.

03

Conditions studied

  • Dentin Sensitivity

Browse trials for

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants in good general health, with self-reported history of dentinal lasting more than 6 months but not more than 10 years.
  • Participants with minimum of 20 natural teeth.
  • At screening, a minimum of four, non-adjacent teeth.

    1. Teeth showing signs of facial/cervical gingival recession and/or signs of erosion or abrasion.
    2. Teeth with Gingival Index score ≤1 and a clinical mobility of ≤1.
    3. Teeth that are determined to be sensitive by the participant following a 1 second air blast to the cervical margin.

Exclusion criteria

Exclusion Criteria:

  • Presence of chronic debilitating disease which, in the opinion of the investigator, could affect study outcomes.
  • Any condition which, in the opinion of the investigator, causes dry mouth.
  • Tooth with evidence of current or recent caries, or reported treatment of decay in 12 months of screening.
  • In the 8 weeks prior to screening use of an oral care product indicated for the relief of DH.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
191 participants (actual)

Study arms

  • Experimental
    Potassium nitrate and sodium fluoride

    3.0% weight by weight (w/w) potassium nitrate mouthwash with 0.02% sodium fluoride

    Drug: Potassium nitrate and sodium fluoride

  • Other
    Standard fluoride dentifrice

    Standard fluoride dentifrice containing 1000 ppm fluoride as sodium monofluorophosphate (SMFP)

    Drug: Standard fluoride dentifrice

Interventions

  • DrugPotassium nitrate and sodium fluoride

    Drug pages: Potassium nitrate · Sodium Fluoride

    3.0% w/w potassium nitrate mouthwash with 0.02% sodium fluoride

  • DrugStandard fluoride dentifrice

    Standard fluoride dentifrice containing 1000 ppm fluoride as SMFP

06

What researchers measure

Primary outcomes

  1. Mean Change From Baseline in Schiff Sensitivity Score at Week 8

    The examiner indicated the participant's response to an evaporaitve air stimulus for each tooth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score is indicative of an imrpovement in sensitivity.

    Time frame: Baseline to 8 week

Secondary outcomes

  1. Mean Change From Baseline in Schiff Sensitivity Score at Week 4

    The examiner indicated the participant's response to an evaporaitve air stimulus for each tooth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score is indicative of an imrpovement in sensitivity.

    Time frame: Baseline to 4 week

  2. Mean Change From Baseline in Tactile Threshold at Week 8

    The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g.

    Time frame: Baseline to 8 week

  3. Mean Change From Baseline in Tactile Threshold at Week 4

    The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g.

    Time frame: Baseline to 4 week

  4. Mean Change From Baseline in Visual Rating Scale (VRS) at Week 8

    Participants rated the intensity of their response to an evaporative air stimulus using a 10 point VRS scale with 1 indicating 'no pain' and 10 indicating 'Intense pain'. A reduction in the score is indicative of an improvement in sensitivity.

    Time frame: Baseline to 8 week

  5. Mean Change From Baseline in VRS at Week 4

    Participants rated the intensity of their response to an evaporative air stimulus using a 10 point VRS scale with 1 indicating 'no pain' and 10 indicating 'Intense pain'. A reduction in the score is indicative of an improvement in sensitivity.

    Time frame: Baseline to 4 week

07

Results

Posted Aug 26, 2015

Participant flow

The participants were recruited at a clinical site in the USA

Participant flow — Overall Study
MilestoneDentifrice Plus Oral RinseDentifrice Alone
Started9596
Completed9595
Not completed01
Withdrew: Lost to follow-up01

Outcome measures

PrimaryMean Change From Baseline in Schiff Sensitivity Score at Week 8

The examiner indicated the participant's response to an evaporaitve air stimulus for each tooth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score is indicative of an imrpovement in sensitivity.

Time frame:
Baseline to 8 week
Reported as:
Least squares mean · Score on scale
Mean Change From Baseline in Schiff Sensitivity Score at Week 8
Score on scaleDentifrice Plus Oral RinseDentifrice Alone
Mean Change From Baseline in Schiff Sensitivity Score at Week 8-1.47 ± 0.065-0.37 ± 0.065
Statistical analysis
  • Dentifrice Plus Oral Rinse vs Dentifrice Alone · ANCOVA · p = 0.0001 (The P-value was less than 0.0001) · Mean difference (net): -1.10 · 95% CI -1.28 to -0.92ANCOVA with a factor for treatment and baseline as covariate
SecondaryMean Change From Baseline in Schiff Sensitivity Score at Week 4

The examiner indicated the participant's response to an evaporaitve air stimulus for each tooth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score is indicative of an imrpovement in sensitivity.

Time frame:
Baseline to 4 week
Reported as:
Mean · Scores on scale
Mean Change From Baseline in Schiff Sensitivity Score at Week 4
Scores on scaleDentifrice Plus Oral RinseDentifrice Alone
Mean Change From Baseline in Schiff Sensitivity Score at Week 4-0.94 ± 0.719-0.31 ± 0.542
SecondaryMean Change From Baseline in Tactile Threshold at Week 8

The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g.

Time frame:
Baseline to 8 week
Reported as:
Mean · Gram(g)
Mean Change From Baseline in Tactile Threshold at Week 8
Gram(g)Dentifrice Plus Oral RinseDentifrice Alone
Mean Change From Baseline in Tactile Threshold at Week 831.32 ± 27.8693.74 ± 13.188
SecondaryMean Change From Baseline in Tactile Threshold at Week 4

The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g.

Time frame:
Baseline to 4 week
Reported as:
Mean · Gram (g)
Mean Change From Baseline in Tactile Threshold at Week 4
Gram (g)Dentifrice Plus Oral RinseDentifrice Alone
Mean Change From Baseline in Tactile Threshold at Week 414.11 ± 21.2760.74 ± 4.434
SecondaryMean Change From Baseline in Visual Rating Scale (VRS) at Week 8

Participants rated the intensity of their response to an evaporative air stimulus using a 10 point VRS scale with 1 indicating 'no pain' and 10 indicating 'Intense pain'. A reduction in the score is indicative of an improvement in sensitivity.

Time frame:
Baseline to 8 week
Reported as:
Mean · Score on scale
Mean Change From Baseline in Visual Rating Scale (VRS) at Week 8
Score on scaleDentifrice Plus Oral RinseDentifrice Alone
Mean Change From Baseline in Visual Rating Scale (VRS) at Week 8-3.05 ± 2.038-1.05 ± 1.673
SecondaryMean Change From Baseline in VRS at Week 4

Participants rated the intensity of their response to an evaporative air stimulus using a 10 point VRS scale with 1 indicating 'no pain' and 10 indicating 'Intense pain'. A reduction in the score is indicative of an improvement in sensitivity.

Time frame:
Baseline to 4 week
Reported as:
Mean · Score on scale
Mean Change From Baseline in VRS at Week 4
Score on scaleDentifrice Plus Oral RinseDentifrice Alone
Mean Change From Baseline in VRS at Week 4-1.64 ± 1.651-0.86 ± 1.295

Adverse events

Collected over Upto 8 weeks. Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Dentifrice Plus Oral Rinse—0/95 (0%)11/95 (11.6%)
Dentifrice Alone—0/96 (0%)7/96 (7.3%)
Most frequent other events
Showing 10 of 18
Most frequent other events
EventDentifrice Plus Oral RinseDentifrice Alone
Sensitivity of teethGastrointestinal disorders2/952/96
Vulvovaginal mycotic infectionInfections and infestations2/950/96
Tooth impactedGastrointestinal disorders1/950/96
SinusitisInfections and infestations1/950/96
Urinary tract infectionInfections and infestations1/950/96
Traumatic ulcerInjury, poisoning and procedural complications1/951/96
EpicondylitisInjury, poisoning and procedural complications1/950/96
Mouth injuryInjury, poisoning and procedural complications1/950/96
Thermal burnInjury, poisoning and procedural complications1/950/96
HeadacheNervous system disorders1/950/96

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Dentifrice Plus Oral RinseDentifrice AloneTotal
Mean41.7 ± 8.6239.7 ± 8.1440.7 ± 8.42
Sex: Female, Male
Sex: Female, Male(Participants)Dentifrice Plus Oral RinseDentifrice AloneTotal
Female8179160
Male141731
08

Study locations

1 site
  • GSK Investigational Site
    Fort Wayne, Indiana 46825, United States
09

References and documents

Publications

  • Hall C, Sufi F, Milleman JL, Milleman KR. Efficacy of a 3% potassium nitrate mouthrinse for the relief of dentinal hypersensitivity: An 8-week randomized controlled study. J Am Dent Assoc. 2019 Mar;150(3):204-212. doi: 10.1016/j.adaj.2018.10.023. PubMed 30803493 ↗
10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2014, a primary completion of Dec 2014 and a completion of Dec 2014. It does not say whether these dates are actual or estimated.

Results were first posted in Aug 2015, 8 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2014
First posted
Aug 27, 2014
Start
Sep 2, 2014
Primary completionActual
Dec 1, 2014
CompletionActual
Dec 5, 2014
Results first posted
Aug 26, 2015
Last update
Aug 27, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02226562
Lead sponsor
GlaxoSmithKline
Responsible party
Sponsor
First posted
Aug 27, 2014
Start date
Sep 2, 2014
Primary completion
Dec 1, 2014
Completion
Dec 5, 2014
Results posted
Aug 26, 2015
Last update
Aug 27, 2018

Study contacts

GSK Clinical Trials
study director · GlaxoSmithKline

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Potassium nitrate · Sodium Fluoride

Start the discussion